Liquidia Corporation - Common Stock (LQDA)
14.17
-0.35 (-2.41%)
NASDAQ · Last Trade: Apr 3rd, 1:57 PM EDT
Via Benzinga · March 20, 2025

Via Benzinga · December 26, 2024

Via Benzinga · October 7, 2024

Via Benzinga · September 11, 2024

Via Benzinga · September 11, 2024

Liquidia announced that the Food and Drug Administration granted tentative approval of YUTREPIA.
Via Benzinga · August 19, 2024

PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more.
Via Benzinga · August 21, 2024

Via Benzinga · August 20, 2024

Via Benzinga · August 19, 2024

The company is hoping to launch a drug that rivals United Therapeutics' Tyvaso DPI.
Via Investor's Business Daily · August 19, 2024

Via Benzinga · August 19, 2024

Via Benzinga · August 19, 2024

LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024